← Leaderboards
Donna M Posluszny
University Of Pittsburgh At Pittsburgh
$2,295,399
Attributed
$2,671,961
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $910.4K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,671,961 · 4
By mechanism
R01$1,994,235 · 2
K23$531,380 · 1
R03$146,346 · 1
Top collaborators
- Robert J Ferguson1 shared
- Brenna C Mcdonald1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Charles F Reynolds$34,949,629
- M Katherine Shear$7,764,773
- Dario Aa Vignali$40,087,127
- Sarah T Stahl$4,318,260
- Timothy H. Monk$4,131,743
Others in their field
Top investigators on “Life”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- David R. Weir · University Of Michigan At Ann Arbor$351,931,649
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$305,871,236
- Chanza Baytop · Westat, Inc.$271,217,917
Research focus
LifeMalignant NeoplasmsCancer PatientAttentionRandomizedRegimenSuccessAllogenicProgramsPerceptionMedicalProblem Solving TherapyHematologic NeoplasmsComplexOutcome StudyProceduresHospitalsProblem SolvingFamily CaregiverFosteringPersonal SatisfactionCopingBaseCaregivers
Grant awards (13)
Dyadic Intervention to Improve Patient-Family Caregiver Team-Based Management of the Medical Regimen after Allogenetic Hematopoietic Cell Transplantation$363,713
R01 · FY2025 · CA · contact PI
Mobile Device CBT for Chemotherapy-Related Cognitive Dysfunction: A Multi-Center Randomized Controlled Trial$564,843
R01 · FY2024 · CA · contact PI
Dyadic Intervention to Improve Patient-Family Caregiver Team-Based Management of the Medical Regimen after Allogenetic Hematopoietic Cell Transplantation$345,528
R01 · FY2024 · CA · contact PI
Dyadic Intervention to Improve Patient-Family Caregiver Team-Based Management of the Medical Regimen after Allogenetic Hematopoietic Cell Transplantation$356,438
R01 · FY2023 · CA · contact PI
Dyadic Intervention to Improve Patient-Family Caregiver Team-Based Management of the Medical Regimen after Allogenetic Hematopoietic Cell Transplantation$363,713
R01 · FY2022 · CA · contact PI
Adherence to the HCT Medical Regimen: Influence of Cancer Patient-Cargiver Dyads$106,276
K23 · FY2015 · CA · contact PI
Adherence to the HCT Medical Regimen: Influence of Cancer Patient-Cargiver Dyads$106,276
K23 · FY2014 · CA · contact PI
Adherence to the HCT Medical Regimen: Influence of Cancer Patient-Cargiver Dyads$106,276
K23 · FY2013 · CA · contact PI
Adherence to the HCT Medical Regimen: Influence of Cancer Patient-Cargiver Dyads$106,276
K23 · FY2012 · CA · contact PI
Adherence to the HCT Medical Regimen: Influence of Cancer Patient-Cargiver Dyads$106,276
K23 · FY2011 · CA · contact PI
Brief Psychosocial Intervention for Head and Neck Cancer Patients and Partners$36,048
R03 · FY2008 · CA · contact PI
Brief Psychosocial Intervention for Head and Neck Cancer Patients and Partners$36,048
R03 · FY2007 · CA · contact PI
Brief Psychosocial Intervention for Head and Neck Cancer Patients and Partners$74,250
R03 · FY2006 · CA · contact PI